NS4B (more specifically, transmembrane domain of NS4B of 2a JFH1 replicon, but not of 1b/Con1 replicon) suppresses STING accumulation during replication of HCV in human hepatoma cells, thus inhibiting IFN-β activation. Here, IFNB1 is linked to hepatocellular carcinoma.